ArcticZymes Technologies ASA (OSL:AZT)

Market Cap	1.22B
Revenue (ttm)	109.99M
Net Income (ttm)	7.20M
Shares Out	51.07M
EPS (ttm)	0.15
PE Ratio	160.24
Forward PE	64.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,868
Average Volume	95,253
Open	24.00
Previous Close	23.20
Day's Range	23.00 - 24.00
52-Week Range	13.00 - 31.40
Beta	0.38
RSI	55.98
Earnings Date	Feb 12, 2026

About OSL:AZT

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 54
• Stock Exchange: Oslo Børs
• Ticker Symbol: AZT

Financial Performance

In 2024, OSL:AZT's revenue was 108.11 million, a decrease of -9.65% compared to the previous year's 119.65 million. Earnings were 8.47 million, a decrease of -56.40%.